Orbis Medicines
Oral macrocycle drug discovery platform.
5
Funding Rounds
$151.5m
Money raised
Overview
Oral macrocycle drug discovery platform.
- Website:
- Business model: B2B
- Headquarters: Copenhagen
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Se*** Ha******* |
|
- |
Funding
Funding series
Funding Series Analysis
The company Orbis Medicines has raised a total of $151.5m in funding over 5 rounds.
Key Insights:
- Orbis Medicines Series A Round, January 2025: $92.8m
- Orbis Medicines February 2024 Seed Funding Round: $28m
- Orbis Medicines February 2024 Seed Funding Round: $28m
- Orbis Medicines July 2022 Funding Round: $2.7m
Orbis Medicines Series A Round, January 2025
$92.8m
Orbis Medicines February 2024 Seed Funding Round
$28m
Orbis Medicines February 2024 Seed Funding Round
$28m
Orbis Medicines July 2022 Funding Round
$2.7m